منابع مشابه
Treatment of catatonia with an anticholinergic agent.
Svejgaard A, Ryder LP (1¢)76): Interaction of HLA nmle-cules with non-immunological ligargls as an exp~ of HLA and disease. Lancet ii:547-549. To the Editor: In their recent overview, "'Benzodiazepines and Ca:atonia," Menza and Harris (1989) describe numerous theories regarding the response of catatonic symptoms to benzodi~zepines. Among these, they state that, "[Llow doses of GABA agonists red...
متن کاملCatatonia Associated with Initiating Paliperidone Treatment
We present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatmen...
متن کاملCatatonia and its treatment.
Psychiatric diagnoses are currently categorized on a syndromic basis. The syndrome of catatonia, however, remains in a diagnostic limbo, acknowledged predominantly as a subtype of schizophrenia. Yet, catatonia is present in about 10% of acutely ill psychiatry patients, only a minority of whom have schizophrenia. Among those with comorbid affective disorders, who comprise the largest subgroup of...
متن کاملSystematic review of catatonia treatment
Objective To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. Materials and methods A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particular interventions for catatonia and/or catatonic symptoms in adult populations and used valid out...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Neuropsychiatry and Clinical Neurosciences
سال: 2013
ISSN: 0895-0172,1545-7222
DOI: 10.1176/appi.neuropsych.11120367